Center for Investigation of Membrane Excitability Diseases, and Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, MO, United States.
Front Immunol. 2020 Oct 9;11:573339. doi: 10.3389/fimmu.2020.573339. eCollection 2020.
Coronavirus (CoV) outbreaks have recently emerged as a global public health threat due to their exceptional zoonotic potential - a feature arising from their ability to infect a diverse range of potential hosts combined with their high capacity for mutation and recombination. After Severe Acute Respiratory Syndrome (SARS) CoV-1 in 2003 and Middle East Respiratory Syndrome (MERS) CoV in 2012, with the current SARS-CoV-2 pandemic we are now in the midst of the third deadly international CoV outbreak in less than 20 years. Coronavirus outbreaks present a critical threat to global public health and an urgent necessity for therapeutic options. Here, we critically examine the current evidence for ion channel activity in CoV proteins and the potential for modulation as a therapeutic approach.
冠状病毒(CoV)的爆发最近成为了全球公共卫生的威胁,这是由于它们异常的人畜共患病潜力——这一特征源于它们能够感染多种潜在宿主的能力,以及它们高突变和重组的能力。继 2003 年的严重急性呼吸综合征(SARS)冠状病毒-1 和 2012 年的中东呼吸综合征(MERS)冠状病毒之后,目前的 SARS-CoV-2 大流行使我们在不到 20 年的时间内经历了第三次致命的国际 CoV 爆发。冠状病毒的爆发对全球公共卫生构成了重大威胁,急需治疗选择。在这里,我们批判性地研究了 CoV 蛋白中离子通道活性的现有证据,以及作为治疗方法的潜在调制。